{
    "Trade/Device Name(s)": [
        "ADVIA 1800 Chemistry Hemoglobin A1c_3 (A1c_3) Automated Pretreatment Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K110934",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081895"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "July 29, 2011",
    "Summary Letter Received Date": "August 1, 2011",
    "Submission Date": "July 8, 2011",
    "Regulation Number(s)": [
        "21CFR864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube",
        "Potassium EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Chemistry systems",
        "ADVIA 1800 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Latex agglutination inhibition assay",
        "Photometric measurement at 410 nm and 694 nm"
    ],
    "Methodologies": [
        "Automated pretreatment",
        "Latex agglutination inhibition",
        "Photometric assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA 1800 Chemistry Hemoglobin A1c_3 automated pretreatment assay for quantitative determination of HbA1c in whole blood for diabetes monitoring.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of Hemoglobin A1c, a diabetes marker, in whole blood on the ADVIA Chemistry systems; measurements used to monitor long-term care of persons with diabetes and A1c/total hemoglobin ratio calculation.",
    "fda_folder": "Hematology"
}